SCHEMBL6401367

SCHEMBL6401367

CC1CC(=O)NN=C1c1cccc(NC(=O)Nc2ccc(F)c(F)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 12/20 0.55
PDE3A Q14432 12/20 0.55
KDR P35968 1/20 0.48
EPHB4 P54760 1/20 0.48
TEK Q02763 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 1/20 0.48
PDE4A P27815 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
LMNA P02545 1/20 0.45
BLM P54132 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404580 0.86 SMN1; SMN2 (0.53) PDE3BPDE3ASMN1; SMN2MAPTPDE4A
SCHEMBL7267127 0.79 PDE3B (0.66) PDE3BPDE3AMAPTPDE4APDE4B
SCHEMBL16157006 0.79 PDE3B (0.66) PDE3BPDE3AMAPTPDE4APDE4B
SCHEMBL16157205 0.79 PDE3B (0.66) PDE3BPDE3AMAPTPDE4APDE4B
SCHEMBL5681167 0.77 PDE3B (0.56) PDE3BPDE3AMAPTPDE4APDE4B
SCHEMBL2845140 0.73 GPR119 (0.70) PDE3BPDE3AMAPTPDE4APDE4B
SCHEMBL11630120 0.73 GPR119 (0.70) PDE3BPDE3AMAPTPDE4APDE4B
SCHEMBL6406401 0.73 KDR (0.51) KDREPHB4TEKMAPTALDH1A1
SCHEMBL16157009 0.73 PDE3B (0.76) PDE3BPDE3ASMN1; SMN2MAPTPDE4A
SCHEMBL7306372 0.72 PDE3B (0.62) PDE3BPDE3AMAPTPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059658-A1 Pyridazinone BAYER AKTIENGESELLSCHAFT (DE) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059658-A1 Pyridazinone TYMP, TPMT, PDXK PDE3B 1587/4885PDE3A 1579/4885KDR 2962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.